Intraarterial chemotherapy of malignant fibrous histiocytoma(MFH) in the maxilla: A clinical case.
- Author:
Yong Kack KIM
1
;
Tae Hee LEE
;
Chul KIM
;
Sung Jin KIM
;
Hyuk KIM
Author Information
1. Department of Oral & Maxillofacial Surgery, Korea Cancer Center Hospital, Korea. moge88@hanmail.net
- Publication Type:Case Report
- Keywords:
Malignant fibrous histiocytoma(MFH);
Chemotherapy
- MeSH:
Clinical Protocols;
Drug Therapy*;
Head;
Maxilla*;
Nasal Cavity;
Neck;
Paranasal Sinuses;
Sarcoma
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2004;30(2):136-142
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Malignant fibrous histiocytoma(MFH) is the malignant part of mesenchymal cell-originated tumor, which is supposed that the tumor is presented various histologic features consisted of fibrosarcomatic and histiocytic portions. When the tumor is arisen in the head and neck region, the most affected sites are the nasal cavity and paranasal sinuses, and secondly the maxillary alveolar bone is occasionally influenced. Therefore, MFH can readily involve the adjacent alveolar bone. The treatment of MFH in the head and neck is various, that is, the involved sites and the differentiation of tumor must be considered when the tumor is treated. The treatment protocols are subjected to general ones of soft tissue sarcoma, and simple or combination therapy is used in the surgery, chemotherapy and radiation therapy. So, we report a clinical case of chemotherapy involving intraarterial chemotherapy, and surgery of malignant fibrous histiocytoma(MFH) in the maxilla, with review of the literature.
